Dr Bruce J Kirenga

Is a Chief Research Scientist and founding Director of the Makerere University Lung Institute (MLI). He is also a Senior Lecturer (Pulmonary Medicine) in the Department of Medicine, Makerere University. Bruce formally trained in Internal Medicine at Makerere University and completed specialty registrar training in Pulmonary Medicine at Mulago National Referral Hospital, he then proceeded to complete an additional year of clinical and research training in the Section of Pulmonary and Critical Care Medicine at Yale University, USA. Bruce has a Masters in clinical research fellowship of the University of Amsterdam offered at the University of Rwanda, School of Public Health in Rwanda. He recently obtained his PhD in Medicine from the University of Groningen, Netherlands. His main interests are in clinical and epidemiological research in the areas of obstructive lung diseases and their determinants as well as infectious lung illnesses. He has over 10 years’ experience of initiating and coordinating programmatic, training and research health projects. He is actively involved in COVID-19 research and has been on the frontline since the pandemic started and is the brains behind the COVID-19 research group at MLI that has implemented several COVID-19 trials.

Prof. Pauline Byakika

Is an Associate Professor of Internal Medicine and Chair of the Department of Medicine at Makerere University College of Health Sciences (MakCHS). She has trained in Clinical Epidemiology and Biostatistics as well as Clinical Pharmacology and Pharmacokinetics.  She is a senior Research Scholar, European Developing Countries Clinical Trials Partnership (EDCTP) at the Infectious Diseases Institute (IDI). She was Principal Investigator on the HONEST trial (Hydroxychloroquine for Treatment of Non-Severe COVID. She sits on the COVID-19 scientific advisory group of the Ministry of health -Uganda.

Prof. Noah Kiwanuka

Prof Kiwanuka is Chair, Department of Epidemiology and Biostatistics, School of Public Health at Makerere University School of Public Health. He is an expert in Epidemiology, Biostatistics and Clinical trials. He teaches Biostatistics andEpidemiology to Masters and PhD students with a focus on longitudinal and multilevel data analysis, randomized clinical trials design and analysis. Dr. Noah is also a lead Investigator on a big number of Research studies. 

Prof. Moses Joloba

 

Prof. Moses Joloba is the current Dean School of Biomedical Sciences, Makerere University College of Health Sciences. He has developed skills in conducting clinical microbiology and molecular biology, laboratory-based research and training as well as building laboratory capacity in Uganda and other countries. Professor Joloba, he established a Molecular Biology, immunology and mycobacteriology laboratories and a Biorepository at the University. He became the Director of the National TB Reference Laboratory now a supranational laboratory Prof. Joloba has won many grants and published over 140 peer reviewed papers, he is a reviewer for 6 journals and trained 18 PhDs to completion.

Dr Joseph Okia

 

A consultant Specialist Physician with 18 years of experience treating patients and saving lives. He has been an Investigator on several studies including Clinical Evaluation of Plant Extract to determine safety, efficacy and pharmacokinetic profile in adults with COVID-19 and Progressive Immune Response and Prevalence of False antibody RDTS following COVID-19 vaccination in Uganda. He is a fellow of the Eastern, Central and Southern Africa college of physicians. He is also a member of the national COVID-19 task force.

Dr Moses Ocan

He is a lecturer of Pharmacology and Graduate coordinator at the Department of Pharmacology & Therapeutics, School of Biomedical Sciences, College of Health Sciences, Makerere University. He is president, Uganda Pharmacological Society. He has been an investigator on several studies with several publications in peer reviewed journals. He is well experienced in drug development and clinical trials.

Dr Eddie Wampande

Is a lecturer and Head of laboratory at Makerere University College of Veterinary medicine. His top areas of expertise are Pulmonary Tuberculosis, Lymphadenitis, HIV/AIDS, and Rabies. He is currently running animal studies on COVID-19 in addition to COVID-19 vaccine development studies.

Dr Jane Nakibuka

 

Is a Senior Consultant Physician-Intensivist and Head of Intensive Care Services at Mulago National Referral Hospital. Jane is a Fellow of the Royal College of Physicians of Edinburgh (FRCPE) and a Fellow of the College of Physicians of East, Central and Southern Africa (FCP, ECSA). She holds a PhD in Medicine and Masters Degree in Internal Medicine from Makerere University. She holds a certificate of fellowship training in Critical Care Medicine from Yale University School of Medicine in USA, a certificate of training in Applied Clinical Research and Evidence Based Medicine from the Infectious Diseases Institute in Uganda. Jane is passionate about improving critical care services in Uganda through active participation in and support of critical care training of health care workers from several institutions in Uganda. As one of Uganda’s clinical leads on the strengthening health workforce through Global learning (SCALE-Critical Care  Program) of the Ministry of Health, she is actively supporting capacity building in the area of critical care medicine in Uganda. Jane is also a researcher with special interest in cardiovascular diseases, stroke, and critical care medicine. She is a member of the Ministerial Scientific Advisory Committee on COVID-19 in Uganda and chairs the Case Management sub-committee. 

Dr Jacqueline Kyosiimire-Lugemwa

 

 

 

Is an Immunologist based at MRC/UVRI and LSHTM in Uganda. Her Research has been on Virologic and Immunologic correlates of protection against HIV disease progression in Uganda; Microbial translocation, Inflammation and T-cell activation in HIV ART-treated patients; and the effect of pre-existing immune status and endemic infections on Hepatitis B vaccine mediated immune responses among HIV negative adult Ugandans. She has a Bachelors in Biomedical Laboratory Technology from Makerere University, an MBA (2021) from University of Kisubi, Uganda and a PhD in Clinical Investigative Science - Immunology from Imperial College, London (June 2012). In 2018, she got a Visiting Scholarship with Quantitative Biosciences Institute at the University of California San Francisco to learn new technologies in science and generate collaborations to enhance her Research career. In 2019, she won the L’Oréal-UNESCO For Women in Science Sub-Saharan Africa Young Talents Awards. Currently, she is working on a project to identify key Antiviral Therapeutic natural products against SARS COV2 using in-vitro studies at Uganda Virus Research Institute. This is supported by the Government of Uganda through the Science Technology and Innovations – Office of the President with collaborative support from UCSF.

Dr Owachi Darius

Is an Infectious Diseases Physician based at Kiruddu National Referral Hospital. He is the head of the Hospital Emergency Department, Head of the COVID19 unit and overseer of the HIV inpatient treatment program. His primary research interest is in infectious diseases such as HIV, Sepsis & Infections such as COVID19. He holds a Masters in Internal Medicine (Makerere University) and a Diploma in Tropical Medicine (London School of Hygiene and Tropical Medicine).

Dr Winters Muttamba

Is a public health scientist, and formally trained in Medicine and Surgery at Makerere University, with additional training in Public health, Project Planning and Management. He has additional training in human genomics and genetics from National Human Genome Research Institute (NHGRI). He is pursuing a PhD in medicine at University of St Andrews; UK. His main research interests are in infectious diseases including HIV, TB and most recently COVID-19. Winters has previously coordinated the Virology, Immunology and Diagnostics Working group of the COVID-19 clinical research coalition, and is coordinator of the COVID-19 research group (COVIDRES) at MLI.